Related Experiment Video
Updated: Apr 17, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
10.0K
Robot-assisted versus laparoscopic partial nephrectomy for localized renal tumors: a meta-analysis
Xiaolong Zhang1, Jiajun Yan1, Yu Ren1
1Department of Urology, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University Shaoxing, Zhejiang, China.
International Journal of Clinical and Experimental Medicine
|February 10, 2015
Summary
Robot-assisted partial nephrectomy (RAPN) shows similar outcomes to laparoscopic partial nephrectomy (LPN) for renal tumors, but offers reduced warm ischemia time. Further long-term studies are needed for definitive oncologic outcome comparisons.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Oncology
Background:
- Robot-assisted partial nephrectomy (RAPN) is increasingly used for localized renal tumors.
- Efficacy of RAPN compared to standard laparoscopic partial nephrectomy (LPN) remains unclear.
- This meta-analysis compares perioperative and oncologic outcomes of RAPN versus LPN.
Purpose of the Study:
- To compare Robot-assisted partial nephrectomy (RAPN) and Laparoscopic partial nephrectomy (LPN).
- To evaluate perioperative and oncologic outcomes for localized renal tumors.
- To synthesize evidence from comparative studies.
Main Methods:
- Systematic literature search of MEDLINE, EMBASE, and OVID databases.
- Inclusion of 14 comparative studies with 1539 participants.
- Statistical analysis using mean difference (MD) and odds ratio (OR) with 95% confidence intervals (CI); quality assessed by Newcastle-Ottawa scale.
Main Results:
- Similar operative time, estimated blood loss (EBL), and length of stay (LOS) between RAPN and LPN.
- RAPN demonstrated a significantly decreased warm ischemia time (WIT) compared to LPN.
- No significant differences in intraoperative, minor, or major postoperative complications, or positive surgical margin rates.
Conclusions:
- RAPN shows comparable operative time, EBL, LOS, perioperative complications, and positive margin rates to LPN.
- RAPN offers a significant advantage in reducing warm ischemia time.
- Long-term follow-up studies are necessary to compare long-term complications and oncologic outcomes.

